Herein, our main objectives were to use PA8 for targeting the AβO–PrP–Fyn axis and test for the first time the potential therapeutic and memory improving effects of PA8 treatment in the well-known transgenic 5XFAD mouse model of AD. The gene discussed is FYN; the disease is Alzheimer disease.